Skip to main content
Log in

Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps

  • Review
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Hypothyroidism presents a large epidemiological burden in India. As a result of subtle and nonspecific clinical symptoms and signs, the condition often goes undiagnosed and is not adequately treated when it is detected. There is heterogeneity in the diagnostic and treatment approaches to hypothyroidism. As a result of the physiological changes in thyroid hormones with age and illness, it is important to tailor the diagnosis and management of this condition in specific populations including pregnant women, infants, children, geriatric patients, and those with comorbid conditions. Enhanced understanding and education of physicians and patients can help to improve the outcomes of treatment in hypothyroidism which should be focused on patient-centered care. Policies and reforms should be crafted and implemented at the national level to curb public health challenges of hypothyroidism. This publication summarizes the recommendations of a national advisory board meeting to identify and bridge the gaps in understanding of the diagnosis and treatment of hypothyroidism in India. As a complement to clinical judgment, these recommendations will foster the diagnosis and management of hypothyroidism in the community and clinics for the benefit of the patients.

Funding

Merck Ltd, India.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bagcchi S. Hypothyroidism in India: more to be done. Lancet. 2014;2:778.

    Google Scholar 

  2. Unnikrishnan AG, Kalra S, Sahay RK, et al. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17:647–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. UshaMenon V, Sundaram KR, Unnikrishnan AG, et al. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc. 2009;107:72–7.

    CAS  Google Scholar 

  4. Andersson M, Takkouche B, Egli I, et al. Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull World Health Organ. 2005;83:518–25.

    PubMed  PubMed Central  Google Scholar 

  5. Agharanya JC. Clinical usefulness of ELISA technique in the assessment of thyroid function. West Afr J Med. 1990;9(4):258–63.

  6. Spencer CA. Assay of thyroid hormones and related substances. [Updated 2017 Feb 20]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. https://www.ncbi.nlm.nih.gov/books/NBK279113/. Accessed 18 Aug 2017.

  7. Biscolla RPM, Chiamolera MI, Kanashiro I, et al. A single 10 mg oral dose of biotin interferes with thyroid function tests. Thyroid. 2017;27:1099–100.

    Article  PubMed  Google Scholar 

  8. Lim SK, Pilon A, Guéchot J. Biotin interferes with free thyroid hormone and thyroglobulin, but not TSH measurements using Beckman-access immunoassays. Ann Endocrinol (Paris). 2017;78:186–7.

    Article  Google Scholar 

  9. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:988–1028.

    Article  PubMed  Google Scholar 

  10. Surana V, Aggarwal S, Khandelwal D, et al. A 2016 clinical practice pattern in the management of primary hypothyroidism among doctors from different clinical specialties in New Delhi. Indian J Endocr Metab. 2017;21:165–77.

    Article  Google Scholar 

  11. Jacob H, Peter C. Screening, diagnosis and management of congenital hypothyroidism: European Society for Paediatric Endocrinology consensus guideline. Arch Dis Child Educ Pract Ed. 2015;100:260–3.

    Article  PubMed  Google Scholar 

  12. Prabhu SR, Mahadevan S, Jagadeesh S, Suresh S. Congenital hypothyroidism: recent Indian data. Indian J Endocrinol Metab. 2015;19:436–7.

    PubMed  PubMed Central  Google Scholar 

  13. Kurtoglu S, Coban D, Ali Akm M, et al. Neonatal sludge: a finding of congenital hypothyroidism. J Clin Res Ped Endo. 2009;1:197–200.

    Google Scholar 

  14. Sareen N, Pradhan R. Need for neonatal screening program in India: a national priority. Indian J Endocrinol Metab. 2015;19:204–20.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Agrawal P, Philip R, Saran S, et al. Congenital hypothyroidism. Indian J Endocr Metab. 2015;19:221–7.

    Article  CAS  Google Scholar 

  16. Rahmani K, Yarahmadi S, Etemad K, et al. Congenital hypothyroidism: optimal initial dosage and time of initiation of treatment: a systematic review. Int J Endocrinol Metab. 2016;14:e36080.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Schoenmakers N, Alatzoglou KS, Chatterjee VK, et al. Recent advances in central congenital hypothyroidism. J Endocrinol. 2015;227:R51–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hashemipour M, Hovsepian S, Ansari A, et al. Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates: a systematic review. Pediatr Neonatol. 2018;59(1):3–14.

    Article  Google Scholar 

  19. Seth A, Aggarwal V, Maheshwari A. Hypothyroidism in children beyond 5 years of age: delayed diagnosis of congenital hypothyroidism. Indian J Pediatr. 2012;79:891–5.

    Article  PubMed  Google Scholar 

  20. Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 2016;170:1008–19.

    Article  PubMed  Google Scholar 

  21. Singh A, Purani C, Mandal A, et al. Prevalence of thyroid disorders in children at a tertiary care hospital in Western India. J Clin Diagn Res. 2016;10:SC01–4.

  22. Khera S, Venkateshwar V, Kanitkar M, et al. Varied presentations of hypothyroidism in children. Med J Armed Forces India. 2011;67:174–6.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Salerno M, Capalbo D, Cerbone M, et al. Subclinical hypothyroidism in childhood—current knowledge and open issues. Nat Rev Endocrinol. 2016;12:734–46.

    Article  CAS  PubMed  Google Scholar 

  24. Gawlik A, Such K, Dejner A, et al. Subclinical hypothyroidism in children and adolescents: is it clinically relevant? Int J Endocrinol. 2015;2015:691071.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Shriraam M, Sridhar M. Subclinical hypothyroidism in children. Indian Pediatr. 2014;51:889–95.

    Article  CAS  PubMed  Google Scholar 

  26. Van Vliet G, Deladoëy J. Diagnosis, treatment and outcome of congenital hypothyroidism. Endocr Dev. 2014;26:50–9.

    Article  CAS  PubMed  Google Scholar 

  27. Jefferys A, Vanderpump M, Yasmin E. Thyroid dysfunction and reproductive health. Obstetr Gynaecol. 2015;17:39–45.

    Google Scholar 

  28. Sahay RK, Sri Nagesh V. Hypothyroidism in pregnancy. Indian J Endocrinol Metab. 2012;16:364–70.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Marwaha RK, Chopra S, Gopalakrishnan S, et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG. 2008;115:602–6.

    Article  CAS  PubMed  Google Scholar 

  30. Sahay R, Kalra S, Magon N. Ensuring an intelligent India: managing hypothyroidism in pregnancy. Indian J Endocrinol Metab. 2011;15:S76–7.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Teng W, Shan Z, Patil-Sisodia K, et al. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1:228–37.

    Article  CAS  PubMed  Google Scholar 

  32. Alexander EK, Pearce EN, Brent GA, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;2017(27):315–89.

    Article  Google Scholar 

  33. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63–8.

    Article  CAS  PubMed  Google Scholar 

  34. Männistö T. Thyroid disease during pregnancy: options for management. Expert Rev Endocrinol Metab. 2013;8:537–47.

    Article  CAS  PubMed  Google Scholar 

  35. Benhadi N, Wiersinga WM, Reitsma JB, et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol. 2009;160(6):985–91.

    Article  CAS  PubMed  Google Scholar 

  36. Zhang Y, Wang H, Pan X, et al. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: a systematic review and meta-analysis. PLoS One. 2017;12:e0175708.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Negro R, Schwartz A, Gismondi R, et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95:1699–707.

    Article  CAS  PubMed  Google Scholar 

  38. Casey BM, Thom EA, Peaceman AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017;376:815–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14:39–55.

    Article  CAS  PubMed  Google Scholar 

  40. Suh S, Kim DK. Subclinical hypothyroidism and cardiovascular disease. Endocrinol Metabol. 2015;30:246–51.

    Article  CAS  Google Scholar 

  41. Ning Yu, Cheng Yun J, Liu Li J, et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. BMC Med. 2017;15:21.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lim HJ, Ahn SH, Hong S, et al. The relationship between subclinical thyroid disease and cardiovascular disease risk score in Koreans. J Korean Med Sci. 2017;32:1626–32.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Sun J, Yao L, Fang Y, et al. Relationship between subclinical thyroid dysfunction and the risk of cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies. Int J Endocrinol. 2017;2017:8130796.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Baek JH, Chung PW, Kim YB, et al. Favourable influence of subclinical hypothyroidism on the functional outcomes in stroke patients. Endocr J. 2010;57:23–9.

    Article  CAS  PubMed  Google Scholar 

  45. Abreu IM, Lau E, de Sousa Pinto B, et al. Subclinical hypothyroidism: to treat or not to treat, that is the question! A systematic review with meta-analysis on lipid profile. Endocr Connect. 2017;6:188–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Redford C, Vaidya B. Subclinical hypothyroidism: should we treat? Post Reprod Health. 2017;23:55–62.

    Article  PubMed  Google Scholar 

  47. Madhuvan HS, Ravishankar SN, Reddy S, et al. A prospective study of thyroid dysfunction in elderly patients and its clinical correlation. Arch Med. 2013;5:1.

  48. Bajaj S, Sachan S, Misra V, et al. Cognitive function in subclinical hypothyroidism in elderly. Indian J Endocrinol Metab. 2014;18:811–4.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Ajish TP, Jayakumar RV. Geriatric thyroidology: an update. Indian J Endocr Metab. 2012;16:542–7.

    Article  CAS  Google Scholar 

  50. Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72:17–33.

    Article  CAS  PubMed  Google Scholar 

  51. Kalra S, Agarwal N, Aggarwal R, et al. Patient-centered management of hypothyroidism. Indian J Endocrinol Metab. 2017;21:475–7.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ward LS. The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism. Arq Bras Endocrinol Metab. 2010;54:435–42.

    Article  Google Scholar 

  53. Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23:781–92.

    Article  CAS  PubMed  Google Scholar 

  54. John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease levothyroxine absorption. Thyroid. 2007;17:763–5.

    Article  CAS  PubMed  Google Scholar 

  55. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787–95.

    Article  CAS  PubMed  Google Scholar 

  56. Irving SA, Vadiveloo T, Leese GP. Drugs that interact with levothyroxine. An observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol. 2015;82:136–41.

    Article  CAS  Google Scholar 

  57. David DG, Bailey. Fruit juice inhibition of uptake transport. A new type of food–drug interaction. Br J Clin Pharmacol. 2010;70:645–55.

    Article  CAS  Google Scholar 

  58. Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev. 2011;32:670–93.

    Article  CAS  PubMed  Google Scholar 

  59. Lechan RM. The dilemma of the nonthyroidal illness syndrome. Acta Biomed. 2008;79:165–71.

    CAS  PubMed  Google Scholar 

  60. Economidou F, Douka E, Tzanela M, et al. Thyroid function during critical illness. Hormones. 2011;10:117–24.

    Article  PubMed  Google Scholar 

  61. Young R, Worthley LIG. Diagnosis and management of thyroid disease and the critically ill patient. Crit Care Resus. 2004;6:295–305.

    CAS  Google Scholar 

  62. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12:646–53.

    Article  PubMed  Google Scholar 

  63. Rao DN. Thyroid cancer—an Indian perspective. In: Shah AH, Samuel AM, Rao RS, editors. Thyroid cancer—an Indian perspective. Mumbai: Quest Publications; 999. pp. 3–16.

  64. Mathew A, George PS, Kalavathy MC, et al. Cancer incidence and mortality: district cancer registry, Trivandrum, South India. Asian Pac J Cancer Prev. 2017;18:1485–91.

    PubMed  PubMed Central  Google Scholar 

  65. Mathew IE, Mathew A. Rising thyroid cancer incidence in Southern India: an epidemic of overdiagnosis? J Endocr Soc. 2017;1:480–7.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Biondi B, Filetti S, Schlumberger M. Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab. 2005;1:32–40.

    Article  CAS  PubMed  Google Scholar 

  67. Haugen BRM, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Hannoush ZC, Weiss RE. Thyroid hormone replacement in patients following thyroidectomy for thyroid cancer. Rambam Maimonides Med J. 2016;7:e0002.

    Article  PubMed Central  Google Scholar 

  69. McMillan CV, Bradley C, Woodcock A, et al. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid. 2004;14:916–25.

    Article  CAS  PubMed  Google Scholar 

  70. Sharma R, Bharti S, Kumar KH. Diet and thyroid—myths and facts. J Med Nutr Nutraceut. 2014;3:60–5.

    Google Scholar 

  71. Benvenga S, PapiG, Antonelli A. Refractory hypothyroidism due to improper storage of levothyroxine tablets. Front Endocrinol (Lausanne). 2017;8:155.

  72. Perumal SS, Prasad S, Surapaneni KS, et al. Health information-seeking behavior among hypothyroid patients at Saveetha Medical College and Hospital. Ethiop J Health Sci. 2015;25:147–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012;1(86):244–51.

    Google Scholar 

  74. Kalra S, Unnikrishnan AG, Sahay R. Thyroidology and public health: the challenges ahead. Indian J Endocrinol Metab. 2011;15:S73–5.

    PubMed  PubMed Central  Google Scholar 

  75. Kumar P, Khandelwal D, Mittal S, et al. Knowledge, awareness, practices and adherence to treatment of patients with primary hypothyroidism in Delhi. Indian J Endocr Metab. 2017;21:429–33.

    Article  Google Scholar 

Download references

Acknowledgements

Funding

The meeting of the advisory board members for discussion of the current topics was funded by Merck Ltd, India. The sponsor also funded the article processing charges for this manuscript.

Medical Writing Assistance

The authors thank Dr. Tarveen Jandoo and Dr. Punit Srivastava of Mediception Science Pvt Ltd for providing medical writing support in the preparation of this publication. Funding for medical writing support was provided by Merck Ltd, India, an affiliate of Merck KGaA, Darmstadt, Germany.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval for this version to be published.

Disclosures

Sanjay Kalra received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. A K Das received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Banshi Saboo received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Deepak Khandelwal received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Mangesh Tiwaskar received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Navneet Agarwal received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Pritam Gupta received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Rakesh Sahay received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Sameer Aggarwal received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Sujoy Ghosh received honoraria as a consultant for Merck Ltd, Mumbai, India for this advisory board meeting. Harshal Chaudhari is an employee of Merck Ltd, India, an affiliate of Merck KGaA, Darmstadt, Germany. Nitin Mulgaonkar is an employee of Merck Ltd, India, an affiliate of Merck KGaA, Darmstadt, Germany.

Compliance with Ethics Guidelines

This article is based on previously published articles and does not contain any studies with human participants or animals performed by any of the authors.

Data Availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjay Kalra.

Additional information

Enhanced digital features

To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.6586295.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalra, S., Das, A.K., Bajaj, S. et al. Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps. Adv Ther 35, 1519–1534 (2018). https://doi.org/10.1007/s12325-018-0744-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-018-0744-7

Keywords

Navigation